Dr. Sara Mobasseri- Egoavil, MD

  • Atlanta, GA
  • Cardiologist
NPI1619984705PAC ID3274523303
Medicare services, 2024
1,486
Medicare patients, 2024
928
Part D claims, 2024
2,043
Clinical trials
1
MIPS score, 2024
92
Practice address
1968 Peachtree Rd NW, Atlanta, GA 30309
Practice phone
Call (404) 605-5000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Piedmont Atlanta

Hospital · Atlanta, Georgia

See all 6 affiliations

Find Dr. Mobasseri- Egoavil's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Sara Mobasseri- Egoavil is a cardiologist in Atlanta, Georgia

Dr. Mobasseri- Egoavil practices at Piedmont Atlanta in Atlanta, Georgia, part of Piedmont Healthcare.

Dr. Mobasseri- Egoavil's NPI, 1619984705, was assigned on August 2, 2006. Dr. Mobasseri- Egoavil graduated from University of Toledo College of Medicine in 1995. Dr. Mobasseri- Egoavil holds Georgia license 57112.

NPI and contact details
Medicare PAC ID
3274523303
NPI enumeration date
August 2, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(404) 605-5000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
57
Medical school graduation
1995

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Sara Mobasseri- Egoavil practices at Piedmont Atlanta in Atlanta, Georgia

Dr. Mobasseri- Egoavil's primary practice is Piedmont Atlanta, at 1968 Peachtree Rd NW, Atlanta, GA 30309 in Fulton County. The practice phone is (404) 605-5000.

  • Piedmont Atlanta
    1968 Peachtree Rd NW, Atlanta, GA 30309 · Fulton CountyPhone(404) 605-5000

Source: Dmand AI Affiliation Data

Dr. Sara Mobasseri- Egoavil is affiliated with 3 sites of care and 3 medical groups

Dr. Mobasseri- Egoavil's primary practice is Piedmont Atlanta in Atlanta, Georgia, part of Piedmont Healthcare. Dr. Mobasseri- Egoavil is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Piedmont Heart Institute. Dmand AI also links Dr. Mobasseri- Egoavil to 2 more medical groups and 1 group practice or clinic, each named with a free account.

See all 6 affiliations for Dr. Mobasseri- Egoavil

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Sara Mobasseri- Egoavil's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mobasseri- Egoavil practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Piedmont AtlantaAvailable with a free account
+2 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Mobasseri- Egoavil practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Piedmont Healthcare and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Sara Mobasseri- Egoavil is one of 665 cardiologists in Georgia

Cardiovascular disease is Dr. Mobasseri- Egoavil's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Mobasseri- Egoavil is licensed in Georgia.

Specialties and state licenses

  • Cardiovascular disease, GeorgiaPrimaryLicense 57112 · taxonomy 207RC0000X

Cardiologists near Dr. Mobasseri- Egoavil

Counts of cardiologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Sara Mobasseri- Egoavil billed Medicare for 1,486 services in 2024

CMS data shows 1,486 Medicare services from Dr. Mobasseri- Egoavil across 23 procedure codes in 2024, for 928 Medicare patients. Medicare paid $76,456 for them.

Medicare services, 20241,486
Medicare patients928
Paid by Medicare$76,456
Procedure codes23

Dr. Mobasseri- Egoavil's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Tests and treatments
2023: 9662024: 9422%
Office and hospital visits
2023: 3452024: 37910%
Surgery
2023: 932024: 10210%
Imaging
2023: 442024: 3716%
Lab and pathology
2023: 372024: 2630%

Where Dr. Mobasseri- Egoavil's Medicare services took place, 2024

  • In an office47232%
  • In a facility1,01468%

Dr. Mobasseri- Egoavil compared with the Georgia median for cardiologists, 2024

  • Dr. Mobasseri- Egoavil
  • Georgia median
Medicare services
1,486vs 1,75415% below
Medicare patients
928vs 73526% above
Part D claims
1,881vs 2,46724% below

Medians across 637 cardiologists in Georgia with Dmand AI profiles that report each measure.

Dr. Mobasseri- Egoavil's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Mobasseri- Egoavil

Need commercial claims for Dr. Mobasseri- Egoavil?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mobasseri- Egoavil and other cardiologists in Georgia.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Sara Mobasseri- Egoavil treated 928 Medicare patients in 2024, average age 76

CMS counts 928 Medicare patients who saw Dr. Mobasseri- Egoavil in 2024. The largest group is 75 to 84, with 409 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mobasseri- Egoavil's median patient age at 65, with 56% women.

Medicare patients, 2024928
Average age76
Average risk score1.75
Also on Medicaid8%

Dr. Mobasseri- Egoavil's Medicare patients by age, 2024

Dr. Mobasseri- Egoavil's Medicare patients by sex, 2024

  • Women48552%
  • Men44348%

Chronic conditions among Dr. Mobasseri- Egoavil's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Ischemic heart disease59%
  4. Arthritis49%
  5. Heart failure47%
  6. Atrial fibrillation43%
  7. Chronic kidney disease36%
  8. Diabetes32%

Share of Medicare patients with each condition. A patient can have several.

Dr. Mobasseri- Egoavil's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 65

Patient panel by sex, all payers

  • Women56%
  • Men43%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Sara Mobasseri- Egoavil wrote 2,043 Medicare Part D claims in 2024

In 2024, Dr. Mobasseri- Egoavil wrote 2,043 Medicare Part D claims for 316 patients. 88% of them were for generic drugs. CMS names the drug for 1,881 of them, across 37 drugs with 11 or more claims each, at $305,935 in total drug cost. In 2023, CMS named 1,917 claims across 36 drugs.

Part D claims, 20242,043
Drugs named by CMS37
Total drug cost$305,935
Part D patients316

Dr. Mobasseri- Egoavil's Part D claims by kind of drug, 2024

  • Generic1,805 claims88%
  • Brand-name238 claims12%

Dr. Mobasseri- Egoavil's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Mobasseri- Egoavil's Part D claims, 2024

  • Antibiotics1%13 of 2,043 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,9172024: 1,8812%

Drugs named by CMS: 37 in 2024, 36 in 2023.

See all prescribing by Dr. Mobasseri- Egoavil

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Sara Mobasseri- Egoavil scored 92 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Mobasseri- Egoavil for performance year 2024, reported through an alternative payment model (APM). Dr. Mobasseri- Egoavil accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Mobasseri- Egoavil's MIPS scores, performance year 2024

  • 92of 100Final score
  • 83.2of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find cardiologists like Dr. Mobasseri- Egoavil by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Sara Mobasseri- Egoavil has worked on 1 clinical trial

Dmand AI links Dr. Mobasseri- Egoavil to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Mitral Valve Insufficiency and Heart Valve Diseases.

Conditions in Dr. Mobasseri- Egoavil's trials

  • Mitral Valve Insufficiency
  • Heart Valve Diseases

Investigators on the most trials with Dr. Mobasseri- Egoavil

Recent clinical trials with Dr. Mobasseri- Egoavil

Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage

Dr. Sara Mobasseri- Egoavil received $14,786 in industry payments from 2016 to 2025

CMS Open Payments shows 180 general payments to Dr. Mobasseri- Egoavil from 21 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 64% of the total. Siemens Medical Solutions USA, Inc. paid the most, $7,776.

General payments to Dr. Mobasseri- Egoavil by program year, 2016 to 2025

General payments to Dr. Mobasseri- Egoavil by kind, 2016 to 2025

$14.8Kin total
  • Travel and lodging$9,47664%
  • Food and beverage$5,25636%
  • Education$540%

Companies that paid Dr. Mobasseri- Egoavil the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Mobasseri- Egoavil

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Sara Mobasseri- Egoavil graduated from University of Toledo College of Medicine

Dr. Mobasseri- Egoavil graduated from University of Toledo College of Medicine in 1995.

  1. Medical schoolUniversity of Toledo College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Sara Mobasseri- Egoavil's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Clinical trials and co-investigatorsClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Sara Mobasseri- Egoavil

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Sara Mobasseri- Egoavil's NPI number?

Dr. Sara Mobasseri- Egoavil's NPI number is 1619984705. It was assigned on August 2, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Sara Mobasseri- Egoavil?

Dr. Sara Mobasseri- Egoavil is a cardiologist in Atlanta, Georgia. The primary specialty in the NPI Registry is Cardiovascular Disease Physician (taxonomy code 207RC0000X).

Where does Dr. Sara Mobasseri- Egoavil practice?

Dr. Mobasseri- Egoavil practices at 1968 Peachtree Rd NW, Atlanta, GA 30309. Dr. Mobasseri- Egoavil's primary practice is Piedmont Atlanta in Atlanta, Georgia, part of Piedmont Healthcare. Dmand AI also links Dr. Mobasseri- Egoavil to 2 medical groups and 1 group practice or clinic.

What is Dr. Sara Mobasseri- Egoavil's office phone number?

The practice phone on file for Dr. Mobasseri- Egoavil is (404) 605-5000.

What is Dr. Sara Mobasseri- Egoavil's medical license number?

Dr. Mobasseri- Egoavil holds Georgia license 57112.

Which hospitals is Dr. Sara Mobasseri- Egoavil affiliated with?

Dr. Mobasseri- Egoavil practices at Piedmont Atlanta in Atlanta, Georgia. Dr. Mobasseri- Egoavil is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center.

What medical group is Dr. Sara Mobasseri- Egoavil part of?

Dr. Mobasseri- Egoavil is linked to Piedmont Heart Institute. Dmand AI links Dr. Mobasseri- Egoavil to 2 more medical groups.

Does Dr. Sara Mobasseri- Egoavil accept Medicare?

Yes. CMS data shows Dr. Mobasseri- Egoavil billed Medicare for 1,486 services in 2024, and Dr. Mobasseri- Egoavil accepts Medicare assignment.

What is Dr. Sara Mobasseri- Egoavil's MIPS score?

Dr. Mobasseri- Egoavil's MIPS final score for performance year 2024 is 92 out of 100, reported through an alternative payment model (APM).

How many Medicare patients does Dr. Sara Mobasseri- Egoavil see?

CMS counts 928 Medicare patients who saw Dr. Mobasseri- Egoavil in 2024, with an average age of 76.

Show 6 more questionsShow fewer questions

What services does Dr. Sara Mobasseri- Egoavil bill to Medicare?

In 2024, Dr. Mobasseri- Egoavil's most billed Medicare services were heart test or procedure (93306), office visit, established patient (99214) and surgery: heart and blood vessels (36415).

Where did Dr. Sara Mobasseri- Egoavil go to medical school?

Dr. Mobasseri- Egoavil graduated from University of Toledo College of Medicine in 1995.

What drugs does Dr. Sara Mobasseri- Egoavil prescribe most?

In 2024 Medicare Part D data, Dr. Mobasseri- Egoavil's most prescribed drugs by claims were Rosuvastatin Calcium, Atorvastatin Calcium and Metoprolol Succinate.

Has Dr. Sara Mobasseri- Egoavil received payments from drug or device companies?

CMS Open Payments shows $14,786 in general payments to Dr. Mobasseri- Egoavil from 21 companies from 2016 to 2025. The largest total came from Siemens Medical Solutions USA, Inc.

How long has Dr. Sara Mobasseri- Egoavil been practicing?

Dr. Mobasseri- Egoavil graduated from medical school in 1995, 31 years ago.

Does Dr. Sara Mobasseri- Egoavil do research?

Dr. Mobasseri- Egoavil has worked on 1 clinical trial.

Selling to cardiovascular disease practices?

See cardiologists in Georgia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)